The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Twist Bioscience Corp (TWST) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.26, or 1.05%, to $25.00. The Twist Bioscience Corp has recorded 26,216 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results.
Twist Bioscience Corp is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Diagnostics & Research industry. At the end of the last regular session, the stock closed at $24.74 and fluctuated between $25.78 as its day high and $23.00 as its day low. The current market capitalization of Twist Bioscience Corp is $1.42B. A total of 1.49 million shares were traded on the day, compared to an average of 984.49K shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, TWST has seen 5 BUY and 17 SELL insider trades, representing the acquisition of 156,355 and the disposition of 7,758 shares. Over the last 12 months, there were 25 BUYs and 94 SELLs from insiders. Insiders purchased 485,465 shares during that period but sold 54,081.
In the most recent transaction, Cho Dennis bought 10,000 shares of TWST for 13.20 per share on May 10. After the transaction, the insider now owns 29,297 company shares. In a previous transaction on Feb 09, Starovasnik Melissa A. sold 1,732 shares at 26.45 per share. TWST shares that Director owns now total 11,340.
Among the insiders who sold shares, JOHANNESSEN JAN disposed of 1,732 shares on Feb 09 at a per-share price of $26.45. This resulted in the Director holding 11,616 shares of TWST after the transaction. In another insider transaction, Banyai William sold 292 shares at $24.05 per share on Jan 04. Company shares held by the insider now total 272,614.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for TWST in the last 3 months, the mean price target is $27.78 with high estimates of $33.00 and low estimates of $19.00. In terms of 52-week highs and lows, TWST has a high of $31.51 and a low of $11.46.
As of this writing, TWST has an earnings estimate of $Toast, Inc. per share for the current quarter. EPS was calculated based on a consensus of Tempest Therapeutics, Inc. estimates, with a high estimate of $Carrols Restaurant Group, Inc. per share and a lower estimate of $Twist Bioscience Corporation.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TWST’s latest balance sheet shows that the firm has $477.86M in Cash & Short Term Investments as of fiscal 2021. There were $62.92M in debt and $63.05M in liabilities at the time. Its Book Value Per Share was $11.46, while its Total Shareholder’s Equity was $580.82M.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TWST is Buy with a score of 4.20.